Literature DB >> 11049794

HIV and Leishmania coinfection: a review of 91 cases with focus on atypical locations of Leishmania.

E Rosenthal1, P Marty, P del Giudice, C Pradier, C Ceppi, J A Gastaut, Y Le Fichoux, J P Cassuto.   

Abstract

A retrospective study was conducted in France in 1998 to determine the clinical features of visceral leishmaniasis (VL) in 91 patients infected cocomitantly with human immunodeficiency virus. Our data suggest that the clinical manifestations of VL may be influenced by the immunological status, with atypical locations of Leishmania amastigotes more frequently found in severely immunocompromised patients. In such patients, the involvement of atypical locations may lead to the discovery of VL.

Entities:  

Mesh：

Year:  2000        PMID： 11049794     DOI： 10.1086/318135

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


  24 in total

Review 1.  Laboratory diagnosis of visceral leishmaniasis.

Authors:  Shyam Sundar; M Rai
Journal:  Clin Diagn Lab Immunol       Date:  2002-09

2.  Visceral leishmaniasis in a patient with AIDS: early pathological diagnosis using conventional histology, PCR and electron microscopy is the key for adequate treatment.

Authors:  Albrecht Stenzinger; Johannes Nemeth; Frederick Klauschen; Christiane Schewe; Axel-Michael Ladhoff; Alexander Muckenhuber; Mariana Schürmann; Dirk Schürmann; Wilko Weichert
Journal:  Virchows Arch       Date:  2012-02-16       Impact factor: 4.064

Review 3.  Parasitic central nervous system infections in immunocompromised hosts: malaria, microsporidiosis, leishmaniasis, and African trypanosomiasis.

Authors:  Melanie Walker; James G Kublin; Joseph R Zunt
Journal:  Clin Infect Dis       Date:  2005-11-23       Impact factor: 9.079

4.  New challenges in the epidemiology and treatment of visceral leishmaniasis in periurban areas.

Authors:  Kathryn M Dupnik; Eliana L Nascimento; Joao F Rodrigues-Neto; Tatjana Keesen; Maria Zélia Fernandes; Iraci Duarte; Selma M B Jeronimo
Journal:  Drug Dev Res       Date:  2011-09       Impact factor: 4.360

Review 5.  Prevalence, severity, and pathogeneses of anemia in visceral leishmaniasis.

Authors:  Yasuyuki Goto; Jingjie Cheng; Satoko Omachi; Ayako Morimoto
Journal:  Parasitol Res       Date:  2016-11-07       Impact factor: 2.289

6.  Leishmaniasis as an opportunistic infection in HIV-infected patients: determinants of relapse and mortality in a collaborative study of 228 episodes in a Mediterreanean region.

Authors:  F Pasquau; J Ena; R Sanchez; J M Cuadrado; C Amador; J Flores; C Benito; C Redondo; J Lacruz; V Abril; J Onofre
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-06       Impact factor: 3.267

7.  [Gastric leishmaniasis. A rare type of gastritis].

Authors:  S Warich-Eitel; S Rauthe; M Eck
Journal:  Pathologe       Date:  2010-05       Impact factor: 1.011

8.  Visceral Leishmaniasis in Hospitalized HIV-Infected Patients in Pernambuco, Brazil.

Authors:  Diego Lins Guedes; Zulma Medeiros; Elis Dionísio da Silva; Audrey Violeta Martins de Vasconcelos; Mariana Santana da Silva; Maria Almerice Lopes da Silva; Paulo Sérgio Ramos de Araújo; Demócrito de Barros Miranda-Filho
Journal:  Am J Trop Med Hyg       Date:  2018-12       Impact factor: 2.345

Review 9.  The relationship between leishmaniasis and AIDS: the second 10 years.

Authors:  Jorge Alvar; Pilar Aparicio; Abraham Aseffa; Margriet Den Boer; Carmen Cañavate; Jean-Pierre Dedet; Luigi Gradoni; Rachel Ter Horst; Rogelio López-Vélez; Javier Moreno
Journal:  Clin Microbiol Rev       Date:  2008-04       Impact factor: 26.132

10.  Specific noninvasive detection of Leishmania donovani in desquamated buccal cell swab samples from human visceral Leishmaniasis-HIV coinfected patients.

Authors:  Sushmita Das; Avishek Halder; Vidya Nand Rabidas; Abhishek Mandal; Pradeep Das
Journal:  J Clin Microbiol       Date:  2014-01-29       Impact factor: 5.948
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.